We are pleased to publish our new report, “Value Added Medicines Report: Discussion document on the contribution of Value Added Medicines in Ireland”, which has
Medicines for Ireland (MFI) welcome opportunity to participate in negotiations to agree a new Framework Agreement on the Supply of Medicines to the Health Services Over recent decades,
Significant price differential between generic medicines and non-generic medicines highlighted in ‘Generic Medicine in Ireland’ report Wednesday 2nd June 2021 Very significant differentials
Medicines for Ireland, the Irish pharmaceutical trade association and the supplier of the majority of medicines in Ireland, is proud to introduce Generic Medicines Day
We are pleased to publish our new report, ‘Filling the Gap: How off patent medicines can improve the equity and quality of cancer care” which
Question mark hangs over long term patient access to medicines due to import and export delays hitting the island of Ireland Keeping an eye on
Medicines for Ireland (MFI), the Irish pharmaceutical trade association and the supplier of the majority of medicines in Ireland, have launched ‘Reductions in the Cost
The appointment of Mairead McGuinness as EU Commissioner-designate for financial services and financial stability by EU Commission President Ursula von der Leyen is a very
After several months of crisis, we can discern some of the key lessons learned from COVID-19 for the future of pharmaceutical policy in Europe. The
Medicines for Ireland (MFI), the Irish pharmaceutical trade association and the supplier of the majority of medicine in Ireland to the HSE and patients directly,
We are committed to working with key stakeholders to affect real change and reforms that ensure Irish patients receive the best medical treatment in the most affordable way.
